Wed, January 30, 2013
Tue, January 29, 2013
[ Tue, Jan 29th 2013 ] - Market Wire
Update on Operations
Mon, January 28, 2013
Sun, January 27, 2013
Fri, January 25, 2013
Thu, January 24, 2013
Wed, January 23, 2013

Uroplasty Inc (NASDAQ:UPI), Down By 8.51% ($0.24) From $2.820 After BUYINS.NET Report Predicted Weakness After Earnings


//stocks-investing.news-articles.net/content/201 .. et-report-predicted-weakness-after-earnings.html
Published in Stocks and Investing on Friday, January 25th 2013 at 7:46 GMT by WOPRAI   Print publication without navigation


January 25, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, January 23rd 2013 stating that Uroplasty Inc (NASDAQ:UPI) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=upi&id=342474

At the time this story was written, Uroplasty Inc (NASDAQ:UPI) is Down By 8.51% ($0.24) From $2.820 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Uroplasty Inc (NASDAQ:UPI) - Uroplasty, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of voiding dysfunctions. The company principally offers Urgent PC Neuromodulation system, a minimally-invasive and office-based therapy for the treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique, a urethral bulking agent for the treatment of adult female stress urinary incontinence due to intrinsic sphincter deficiency, as well as for the treatment of male stress incontinence, fecal incontinence, and vesicoureteral reflux. It also provides PTQ Implants, which offers a minimally-invasive, soft-textured permanent implant for treatment of fecal incontinence; VOX Implants, a tissue bulking material for otolaryngology vocal cord rehabilitation applications; and is involved in the distribution of wound care products. The company sells its products primarily to urologists, urogynecologists, and gynecologists through a direct sales organization in the United States, the United Kingdom, and the Netherlands, as well as through distributors in other markets. Uroplasty, Inc. was incorporated in 1992 and is headquartered in Minnetonka, Minnesota..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Uroplasty Inc (NASDAQ:UPI) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net


Publication Contributing Sources